Article
Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment.
Current pharmaceutical design - 1 Jan 2015
Siasos Gerasimos, Zaromitidou Marina, Oikonomou Evangelos, Mourouzis Konstantinos, Tsalamandris Sotiris, Kioufis Stamatios, Kokkou Eleni, Vavuranakis Manolis, Zografos Theodoros, Antonopoulos Alexis, Dimitropoulos Stathis, Stefanadis Christodoulos, Papavassiliou Athanasios G, Tousoulis Dimitris
Abstract excerpt
BACKGROUND: Clopidogrel's ability to inhibit platelet function determined its clinical usefulness. The role of CYP2C19*2 genotype on antiplatelet treatment is recently under question. Arterial wall properties and inflammation are key players in atherosclerosis development. Hence, we evaluated the impact of CYP2C19*2 genetic polymorphism on endothelial function, arterial stiffness and inflammation in coronary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
